These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 33249717)
1. Insight into the hypercoagulable state of high-risk thrombotic APS patients: Contribution of aβ2GPI and aPS/PT antibodies. Pontara E; Cattini MG; Cheng C; Bison E; Denas G; Pengo V J Thromb Haemost; 2021 Mar; 19(3):805-813. PubMed ID: 33249717 [TBL] [Abstract][Full Text] [Related]
2. Added value of antiphosphatidylserine/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies. Vandevelde A; Chayoua W; de Laat B; Moore GW; Musiał J; Zuily S; Wahl D; Devreese KMJ J Thromb Haemost; 2022 Sep; 20(9):2136-2150. PubMed ID: 35713971 [TBL] [Abstract][Full Text] [Related]
3. Extra-criteria antiphospholipid antibodies in patients with small vessel brain lesions and clinical manifestations associated with antiphospholipid syndrome. Estévez MÁ; Lanio N; Molina Á; Jiménez-León MR; Picado MJ; Esteban E; Sánchez S; Pallarés L; Julià MR J Stroke Cerebrovasc Dis; 2023 May; 32(5):107034. PubMed ID: 36842350 [TBL] [Abstract][Full Text] [Related]
4. Anti-phosphatidylserine/prothrombin complex antibodies (aPS/PT) increase the risk for thrombosis based on lupus anticoagulant positivity. Zhang Y; Su Y; Guo H; Wang L; Li A; Wang C; Zhang J; Qiao R Clin Biochem; 2023 Feb; 112():17-23. PubMed ID: 36535385 [TBL] [Abstract][Full Text] [Related]
5. Antibody profiles comprising anti phosphatidylserine/prothrombin differently affect thrombin generation and protein C resistance in antiphospholipid antibody carriers. Cheng C; Pontara E; Tonello M; Cattini MG; Bison E; Denas G; Pengo V Clin Chim Acta; 2020 Nov; 510():796-801. PubMed ID: 32976830 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of antibodies to phosphatidylserine/prothrombin complex for antiphospholipid syndrome in Chinese patients. Zhu L; Li C; Liu N; Yang X; Jia RL; Mu R; Su Y; Li ZG Clin Rheumatol; 2017 Feb; 36(2):401-406. PubMed ID: 28050648 [TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid syndrome: Reversal of antiphosphatidylserine/prothrombin-induced activated protein C resistance. Pontara E; Cattini MG; Bison E; Cheng C; Denas G; Pengo V Thromb Res; 2022 Oct; 218():17-23. PubMed ID: 35973396 [TBL] [Abstract][Full Text] [Related]
8. Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies. Radin M; Barinotti A; Foddai SG; Cecchi I; Rubini E; Roccatello D; Menegatti E; Sciascia S Immunol Res; 2021 Aug; 69(4):372-377. PubMed ID: 34245429 [TBL] [Abstract][Full Text] [Related]
10. "Non-criteria" antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort. Liu T; Gu J; Wan L; Hu Q; Teng J; Liu H; Cheng X; Ye J; Su Y; Sun Y; Zhou J; Norman GL; Wang X; Yang C; Shi H Arthritis Res Ther; 2020 Feb; 22(1):33. PubMed ID: 32085759 [TBL] [Abstract][Full Text] [Related]
11. Beyond the classics: The emerging value of anti-phosphatidylserine/prothrombin antibodies in antiphospholipid syndrome. Ding Z; Pan H; Yang Z; Yang C; Shi H Clin Immunol; 2023 Nov; 256():109804. PubMed ID: 37838215 [TBL] [Abstract][Full Text] [Related]
13. Anti-β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies interfere with cleavage of factor V(a) by activated protein C. Noordermeer T; Chemlal S; Jansma JJ; van der Vegte V; Schutgens REG; Limper M; de Groot PG; Meijers JCM; Urbanus RT J Thromb Haemost; 2023 Sep; 21(9):2509-2518. PubMed ID: 37290588 [TBL] [Abstract][Full Text] [Related]
14. Determination of Thrombogenicity Levels of Various Antiphospholipid Antibodies by a Modified Thrombin Generation Assay in Patients with Suspected Antiphospholipid Syndrome. Bradáčová P; Slavík L; Skoumalová A; Úlehlová J; Kriegová E; Manukyan G; Friedecký D; Piskláková B; Ullrychová J; Procházková J; Hluší A Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012233 [TBL] [Abstract][Full Text] [Related]
15. Double positivity of anti-β Yun J; Gu J; Kim HK J Thromb Thrombolysis; 2021 Nov; 52(4):1133-1136. PubMed ID: 33914240 [TBL] [Abstract][Full Text] [Related]
16. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β Nakamura H; Oku K; Amengual O; Ohmura K; Fujieda Y; Kato M; Bohgaki T; Yasuda S; Atsumi T Arthritis Care Res (Hoboken); 2018 Apr; 70(4):627-634. PubMed ID: 28686816 [TBL] [Abstract][Full Text] [Related]
17. Anti-phosphatidyl-serine/prothrombin antibodies (aPS/PT) in isolated lupus anticoagulant (LA): is their presence linked to dual test positivity? Tonello M; Bison E; Cattini MG; Pontara E; Iaccarino L; Denas G; Cheng C; Pengo V Clin Chem Lab Med; 2021 Nov; 59(12):1950-1953. PubMed ID: 34390635 [TBL] [Abstract][Full Text] [Related]
18. Close link between antiphosphatidylserine/prothrombin antibodies, lupus anticoagulant, and activated protein C resistance in tetra antiphospholipid antibody-positive subjects. Pontara E; Bison E; Cattini MG; Tonello M; Denas G; Pengo V J Thromb Haemost; 2023 Nov; 21(11):3138-3144. PubMed ID: 37422199 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Diagnostic Value of Non-criteria Antibodies for Antiphospholipid Syndrome Patients in a Chinese Cohort. Hu C; Li S; Xie Z; You H; Jiang H; Shi Y; Qi W; Zhao J; Wang Q; Tian X; Li M; Zhao Y; Zeng X Front Immunol; 2021; 12():741369. PubMed ID: 34567005 [TBL] [Abstract][Full Text] [Related]
20. Anti-protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome. Arachchillage DR; Efthymiou M; Mackie IJ; Lawrie AS; Machin SJ; Cohen H J Thromb Haemost; 2014 Nov; 12(11):1801-9. PubMed ID: 25196808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]